| Product Code: ETC4746705 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Mauritius Influenza Vaccine Market is projected to witness mixed growth rate patterns during 2025 to 2029. The growth rate begins at 10.60% in 2025, climbs to a high of 13.93% in 2027, and moderates to 7.74% by 2029.

The Influenza Vaccine market in Mauritius is projected to grow at a high growth rate of 13.93% by 2027, highlighting the country's increasing focus on advanced technologies within the Africa region, where Egypt holds the dominant position, followed closely by South Africa, Ethiopia, Algeria and Nigeria, shaping overall regional demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Influenza Vaccine Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Influenza Vaccine Market - Industry Life Cycle |
3.4 Mauritius Influenza Vaccine Market - Porter's Five Forces |
3.5 Mauritius Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Mauritius Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Mauritius Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Mauritius Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Mauritius Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Mauritius Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Influenza Vaccine Market Trends |
6 Mauritius Influenza Vaccine Market Segmentations |
6.1 Mauritius Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Mauritius Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Mauritius Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Mauritius Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Mauritius Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Mauritius Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Mauritius Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Mauritius Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Mauritius Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Mauritius Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Mauritius Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Mauritius Influenza Vaccine Market Export to Major Countries |
7.2 Mauritius Influenza Vaccine Market Imports from Major Countries |
8 Mauritius Influenza Vaccine Market Key Performance Indicators |
9 Mauritius Influenza Vaccine Market - Opportunity Assessment |
9.1 Mauritius Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Mauritius Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Mauritius Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Mauritius Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Mauritius Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Mauritius Influenza Vaccine Market - Competitive Landscape |
10.1 Mauritius Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here